The development and manufacturing of sterile injectables is highly complex and capital intensive.
The operative cost for injectable is high as almost all injectables in present pharma market are toxic and infectious in natural, consequently, requiring a higher level of quality and significant care needs to be taken in order to ensure safe manufacture, packaging, storage, and distribution.
Increasing use of biologics in healthcare industry, with the gaining prominence, the emergence of antibody-drug conjugates (ADCs) and monoclonal antibodies (MA) into the drug development and clinical pipeline, has spurred growth of the sterile injectable market worldwide.
In 2019, the market size of Sterile Injectables is 340 million US$ and it will reach 580 million US$ in 2025, growing at a CAGR of 6.9% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sterile Injectables.
This report studies the global market size of Sterile Injectables, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Sterile Injectables sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Baxter International Inc
AstraZeneca plc
Merck & Co., Inc
Novartis AG
Johnson & Johnson Services, Inc
...
Market Segment by Product Type
Large Molecules
Small Molecules
Market Segment by Application
Cancer
Diabetes
Cardiovascular Diseases
Central Nervous Systems
Infectious Disorders
Musculoskeletal
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Sterile Injectables status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Sterile Injectables manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Sterile Injectables are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Summary:
Get latest Market Research Reports on Sterile Injectables. Industry analysis & Market Report on Sterile Injectables is a syndicated market report, published as Global (United States, European Union and China) Sterile Injectables Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Sterile Injectables market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.